In last trading session, Processa Pharmaceuticals Inc (NASDAQ:PCSA) saw 8.66 million shares changing hands with its beta currently measuring 1.38. Company’s recent per share price level of $0.26 trading at -$0.03 or -9.13% at ring of the bell on the day assigns it a market valuation of $6.88M. That closing price of PCSA’s stock is at a discount of -1092.31% from its 52-week high price of $3.10 and is indicating a premium of 42.31% from its 52-week low price of $0.15.
For Processa Pharmaceuticals Inc (PCSA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Processa Pharmaceuticals Inc (NASDAQ:PCSA) trade information
Upright in the red during last session for losing -9.13%, in the last five days PCSA remained trading in the green while hitting it’s week-highest on Friday, 06/20/25 when the stock touched $0.26 price level, adding 21.21% to its value on the day. Processa Pharmaceuticals Inc’s shares saw a change of -86.60% in year-to-date performance and have moved 1.04% in past 5-day. Processa Pharmaceuticals Inc (NASDAQ:PCSA) showed a performance of 9.60% in past 30-days.
Wall Street analysts have assigned a consensus price target of 9 to the stock, which implies a rise of 97.11% to its current value. Analysts have been projecting 9 as a low price target for the stock while placing it at a high target of 9. It follows that stock’s current price would drop -3361.54% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3361.54% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 22.65% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 77.00% while estimates for its earnings growth in next 5 years are of 42.13%.
